Prognostic factors in spinal chordoma: A systematic review

Clinical Neurology and Neurosurgery

Volumn 139, Issue , 2015, Pages 110-118

  Zou, Ming Xiang ^a   Huang, Wei ^b   Wang, Xiao Bin ^a   Li, Jing ^a   Lv, Guo Hua ^a   Deng, You Wen ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Chordoma; Factors; Humans; Prognosis; Spine; Survival analysis

Indexed keywords

ARTICLE; CERVICAL SPINE; CHORDOMA; FRANKEL GRADE; HUMAN; PROGNOSIS; REOPERATION; SPINE SURGERY; SPINE TUMOR; SURVIVAL; SYSTEMATIC REVIEW; SPINAL NEOPLASMS;

CHORDOMA; HUMANS; SPINAL NEOPLASMS;

EID: 84942887052     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2015.09.012     Document Type: Review

References (60)

1. M.L. McMaster, A.M. Goldstein, C.M. Bromley, N. Ishibe, and D.M. Parry Chordoma: incidence and survival patterns in the United States, 1973-1995 Cancer Causes Control 12 2001 1 11
2. M. Bydon, K. Papadimitriou, T. Witham, J.P. Wolinsky, A. Bydon, D. Sciubba, and et al. Novel therapeutic targets in chordoma Expert Opin. Ther. Targets 16 11 2012 1139 1143
3. J. Mirra, S. Nelson, and C. Della Rocca Chordoma C.D. Fletcher, K. Unni, F. Mertens, Pathology and Genetics of Tumours of Soft Tissue and Bone 2002 IARC Press Lyon, France 316 317
4. R. Chugh, H. Tawbi, D.R. Lucas, J.S. Biermann, S.M. Schuetze, and L.H. Baker Chordoma: the nonsarcoma primary bone tumor Oncologist 12 11 2007 1344 1350
5. E.Y. Cheng, R.A. Ozerdemoglu, E.E. Transfeldt, and R.C. Thompson Jr. Lumbosacral chordoma. Prognostic factors and treatment Spine (Phila Pa 1976) 24 16 1999 1639 1645
6. C. Catton, B. O'Sullivan, R. Bell, N. Laperriere, B. Cummings, V. Fornasier, and et al. Chordoma: long-term follow-up after radical photon irradiation Radiother. Oncol. 41 1 1996 67 72
7. A. Azzarelli, V. Quagliuolo, S. Cerasoli, R. Zucali, P. Bignami, V. Mazzaferro, and et al. Chordoma: natural history and treatment results in 33 cases J. Surg. Oncol. 37 3 1988 185 191
8. J.E. York, A. Kaczaraj, D. Abi-Said, G.N. Fuller, J.M. Skibber, N.A. Janjan, and et al. Sacral chordoma: 40-year experience at a major cancer center Neurosurgery 44 1 1999 74 79 discussion 79-80
9. B. Kayani, S.A. Hanna, M.D. Sewell, A. Saifuddin, S. Molloy, and T.W. Briggs A review of the surgical management of sacral chordoma Eur. J. Surg. Oncol. 40 11 2014 1412 1420
10. P.C. Hsieh, R. Xu, D.M. Sciubba, M.J. McGirt, C. Nelson, T.F. Witham, and et al. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients Spine (Phila Pa 1976) 34 20 2009 2233 2239
11. B. Fuchs, I.D. Dickey, M.J. Yaszemski, C.Y. Inwards, and F.H. Sim Operative management of sacral chordoma J. Bone Joint Surg. Am. 87 10 2005 2211 2216
12. T. Yonemoto, S. Tatezaki, T. Takenouchi, T. Ishii, T. Satoh, and H. Moriya The surgical management of sacrococcygeal chordoma Cancer 85 1999 878 883
13. D. Baratti, A. Gronchi, E. Pennacchioli, L. Lozza, M. Colecchia, M. Fiore, and M. Santinami Chordoma: natural history and results in 28 patients treated at a single institution Ann. Surg. Oncol. 10 2003 291 296
14. P. Bergh, L.G. Kindblom, B. Gunterberg, F. Remotti, W. Ryd, and J.M. Meis-Kindblom Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients Cancer 88 9 2000 2122 2134
15. S. Osaka, O. Kodoh, H. Sugita, E. Osaka, Y. Yoshida, and J. Ryu Clinical significance of a wide excision policy for sacrococcygeal chordoma J. Cancer Res. Clin. Oncol. 132 2006 213 218
16. P. Ruggieri, A. Angelini, G. Ussia, M. Montalti, and M. Mercuri Surgical margins and local control in resection of sacral chordomas Clin. Orthop. Relat. Res. 468 11 2010 2939 2947
17. H. Zhou, C.B. Chen, J. Lan, C. Liu, X.G. Liu, L. Jiang, and et al. Differential proteomic profiling of chordomas and analysis of prognostic factors J. Surg. Oncol. 102 7 2010 720 727
18. K.W. Chen, H.L. Yang, J. Lu, J.Y. Liu, and X.Q. Chen Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients Spinal Cord 48 2 2010 166 171
19. M.J. McGirt, Z.L. Gokaslan, and K.L. Chaichana Preoperative grading scale to predict survival in patients undergoing resection of malignant primaryosseous spinal neoplasms Spine J. 11 3 2011 190 196
20. X. Li, S. Wang, Y. Chen, G. Liu, and X. Yang Overexpression of CD40 in sacral chordomas and its correlation with low tumor recurrence Onkologie 36 10 2013 567 571
21. T. Meng, H. Yin, B. Li, Z. Li, W. Xu, W. Zhou, and et al. Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center Neuro-Oncology 17 5 2015 725 732
22. M.X. Zou, W. Huang, X.B. Wang, G.H. Lv, J. Li, and Y.W. Deng Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma Int. J. Clin. Exp. Pathol. 7 8 2014 4877 4885
23. J.H. Schwab, J.H. Healey, P. Rose, J. Casas-Ganem, and P.J. Boland The surgical management of sacral chordomas Spine (Phila Pa 1976) 34 24 2009 2700 2704
24. H. Yang, L. Zhu, N.A. Ebraheim, X. Liu, S. Castillo, T. Tang, and et al. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization Spine J. 9 12 2009 972 980
25. T. Naka, C. Boltze, D. Kuester, T.O. Schulz, A. Samii, C. Herold, and et al. Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma Am. J. Clin. Pathol. 122 6 2004 926 930
26. K.W. Chen, H.L. Yang, J. Lu, G.L. Wang, Y.M. Ji, G.Z. Wu, and et al. Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma J. Neurooncol. 101 3 2011 357 363
27. H. Hu, H.L. Yang, J. Lu, K.W. Chen, Y.H. Qiu, W. Liu, and et al. Association of telomerase expression with recurrence of sacral chordoma Ann. Oncol. 23 10 2012 2772
28. C.V. de Castro, G. Guimaraes, S. Aguiar Jr., A. Lopes, G. Baiocchi, I.W. da Cunha, and et al. Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome Hum. Pathol. 44 9 2013 1747 1755
29. C. Chen, H.L. Yang, K.W. Chen, G.L. Wang, J. Lu, Q. Yuan, and et al. High expression of survivin in sacral chordoma Med. Oncol. 30 2 2013 529
30. K. Zhang, H. Chen, G. Wu, K. Chen, and H. Yang High expression of SPHK1 in sacral chordoma and association with patients' poor prognosis Med. Oncol. 31 11 2014 247
31. M. Zhou, K. Chen, H. Yang, G. Wang, J. Lu, Y. Ji, and et al. Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma J. Neurooncol. 116 1 2014 77 82
32. R. Akhavan-Sigari, M.R. Gaab, V. Rohde, M. Abili, and H. Ostertag Expression of PDGFR-α, EGFR and c-MET in spinal chordoma: a series of 52 patients Anticancer Res. 34 2 2014 623 630
33. K. Chen, J. Mo, M. Zhou, G. Wang, G. Wu, H. Chen, and et al. Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis Med. Oncol. 31 4 2014 886
34. R. Akhavan-Sigari, M.R. Gaab, V. Rohde, M. Abili, and H. Ostertag Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma Eur. Spine J. 23 11 2014 2416 2422
35. Z. Duan, J. Shen, X. Yang, P. Yang, E. Osaka, E. Choy, and et al. Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma J. Orthop. Res. 32 5 2014 695 701
36. J.A. Bramer, J.H. van Linge, R.J. Grimer, and R.J. Scholten Prognostic factors in localized extremity osteosarcoma: a systematic review Eur. J. Surg. Oncol. 35 10 2009 1030 1036
37. J.A. Hayden, P. Côté, and C. Bombardier Evaluation of the quality of prognosis studies in systematic reviews Ann. Intern. Med. 144 6 2006 427 437
38. S. Stacchiotti, P.G. Casali, S. Lo Vullo, L. Mariani, E. Palassini, M. Mercuri, and et al. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgicallytreated at two referral centers Ann. Surg. Oncol. 17 1 2010 211 219
39. N. Baldini, K. Scotlandi, G. Barbanti-Bròdano, M.C. Manara, D. Maurici, G. Bacci, and et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome N. Engl. J. Med. 333 21 1995 1380 1385
40. R. Harbour, and J. Miller A new system for grading recommendations in evidence based guidelines BMJ 323 7308 2001 334 336
41. C. Thieblemont, P. Biron, F. Rocher, D. Bouhour, J.Y. Bobin, J.P. Gérard, and et al. Prognostic factors in chordoma: role of postoperative radiotherapy Eur. J. Cancer 31A 13-14 1995 2255 2259
42. D. Mukherjee, K.L. Chaichana, Z.L. Gokaslan, O. Aaronson, J.S. Cheng, and M.J. McGirt Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003 J. Neurosurg. Spine 14 2 2011 143 150
43. D. Mukherjee, K.L. Chaichana, O. Adogwa, Z. Gokaslan, O. Aaronson, J.S. Cheng, and et al. Association of extent of local tumor invasion and survival in patients with malignant primary osseousspinal neoplasms from the surveillance, epidemiology, and end results (SEER) database World Neurosurg. 76 6 2011 580 585
44. S. Berven, D. Zurakowski, H.J. Mankin, M.C. Gebhardt, D.S. Springfield, and F.J. Hornicek Clinical outcome in chordoma: utility of flow cytometry in DNA determination Spine (Phila Pa 1976) 27 4 2002 374 379
45. D. Mukherjee, K.L. Chaichana, S.L. Parker, Z.L. Gokaslan, and M.J. McGirt Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database Eur. Spine J. 22 6 2013 1375 1382
46. P.P. Varga, Z. Szövérfi, C.G. Fisher, S. Boriani, Z.L. Gokaslan, M.B. Dekutoski, and et al. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival Eur. Spine J. 2014 10.1007/s00586-014-3728-6
47. C.G. Fisher, D.D. Saravanja, M.F. Dvorak, Y.R. Rampersaud, P.W. Clarkson, J. Hurlbert, and et al. Surgical management of primary bone tumors of the spine: validation of an approach to enhance cure and reduce local recurrence Spine (Phila Pa 1976) 36 10 2011 830 836
48. Y. Wang, J. Xiao, Z. Wu, Q. Huang, W. Huang, Q. Zhu, and et al. Primary chordomas of the cervical spine: a consecutive series of 14 surgically managed cases J. Neurosurg. Spine 17 4 2012 292 299
49. Y.L. Chen, N. Liebsch, W. Kobayashi, S. Goldberg, D. Kirsch, G. Calkins, and et al. Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas Spine (Phila Pa 1976) 38 15 2013 E930 E936
50. T.F. DeLaney, N.J. Liebsch, F.X. Pedlow, J. Adams, S. Dean, B.Y. Yeap, and et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas Int. J. Radiat. Oncol. Biol. Phys. 74 3 2009 732 739
51. T.D. Wagner, W. Kobayashi, S. Dean, S.I. Goldberg, D.G. Kirsch, H.D. Suit, and et al. Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dosepostoperative irradiation in the treatment of tumors involving the bone Int. J. Radiat. Oncol. Biol. Phys. 73 1 2009 259 266
52. R. Imai, T. Kamada, H. Tsuji, S. Sugawara, I. Serizawa, H. Tsujii, and et al. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials Int. J. Radiat. Oncol. Biol. Phys. 77 5 2010 1470 1476
53. X. Li, Z. Ji, Y. Ma, X. Qiu, Q. Fan, and B. Ma Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and matrix metalloproteinase-2 insacral chordomas Oncol. Lett. 3 6 2012 1268 1274
54. C. Yang, J.H. Schwab, A.J. Schoenfeld, F.J. Hornicek, K.B. Wood, G.P. Nielsen, and et al. A novel target for treatment of chordoma: signal transducers and activators of transcription 3 Mol. Cancer Ther. 8 9 2009 2597 2605
55. L. Zhang, S. Guo, J.H. Schwab, G.P. Nielsen, E. Choy, S. Ye, and et al. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma PLOS ONE 8 9 2013 e75851
56. G. Rao, D. Suki, I. Chakrabarti, I. Feiz-Erfan, M.G. Mody, I.E. McCutcheon, and et al. Surgical management of primary and metastatic sarcoma of the mobile spine J. Neurosurg. Spine 9 2 2008 120 128
57. Stacchiotti S1, A. Marrari, E. Tamborini, E. Palassini, E. Virdis, A. Messina, and et al. Response to imatinib plus sirolimus in advanced chordoma Ann. Oncol. 20 2009 1886 1894
58. S. Stacchiotti, A. Longhi, V. Ferraresi, G. Grignani, A. Comandone, R. Stupp, and et al. Phase II study of imatinib in advanced chordoma J. Clin. Oncol. 30 9 2012 914 920
59. S. Stacchiotti, E. Tamborini, S. Lo Vullo, F. Bozzi, A. Messina, C. Morosi, and et al. Phase II study on lapatinib in advanced EGFR-positive chordoma Ann. Oncol. 24 7 2013 1931 1936
60. S.M. Bentzen Prognostic factor studies in oncology: osteosarcoma as a clinical example Int. J. Radiat. Oncol. Biol. Phys. 49 2 2001 513 518